News

News

 

 

Dolomite and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests

2nd April 2020

Dolomite Microfluidics is pleased to announce a new collaboration with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes to accelerate the validation and wide-release of Mologic’s COVID-19 diagnostic test.

Read more

Dolomite and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests

A COVID-19 update to all our customers and members of the scientific community

18th March 2020

A COVID-19 update to all our customers and members of the scientific community. We would like to reassure you that, at this challenging time, we are indeed fully operational and will provide the same level of support as usual. Furthermore, we are pleased to announce that we will extend our educational online content. Please read this article & stay tuned for more information on this!

Read more

Dolomite Microfluidics shares its expertise in core-shell microparticle production

5th March 2020

Read more about our latest application note, Microfluidic Production of 20 to 50 μm Core-Shell PLGA Beads, which is enabling scientists around the globe to benefit from the company’s in-depth knowledge of the encapsulation of hydrophilic materials, such as active pharmaceutical ingredients (APIs).

Read more

Dolomite Microfluidics shares its expertise in core-shell microparticle production

Dolomite Microfluidics highlights of MicroTAS 2019

14th November 2019

Another year of MicroTAS has passed us by, and we’d like to give you an update on our time spent at the 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences!

Read more

Dolomite Microfluidics highlights of MicroTAS 2019

Taking a microfluidic approach to the production of taxane chemotherapeutics

15th October 2019

Researchers at the University of Porto in Porto, Portugal are using Dolomite Microfluidics chips to manufacture diverse therapeutic nanoplatforms, including an advanced microfluidic method for manufacture of taxane-loaded nanoparticles for cancer treatment.

Read more

Taking a microfluidic approach to the production of taxane chemotherapeutics